Table 3. Uni- and multivariate proportional hazard regression analysis for competing events of 90-day organ failure development.
Univariate Fine-Gray proportional hazard regression |
Multivariate Fine-Gray proportional hazard regression |
|||||
---|---|---|---|---|---|---|
Hazard ratio |
95%CI | p value | Hazard ratio |
95%CI | p value | |
Age | 1.055 | 0.9949–1.119 | 0.073 | 1.142 | 1.048–1.243 | 0.0024 |
Gender | 0.7412 | 0.2262–2.428 | 0.62 | |||
Cirrhosis* | 2.153 | 0.2506–18.5 | 0.48 | |||
Ascites* | 8.396 | 2.216–31.81 | 0.0017 | 2.335 | 0.5189–10.500 | 0.27 |
Encephalopathy* | 1.649 | 0.4481–6.069 | 0.45 | |||
MELD score | 1.246 | 1.101–1.411 | 0.00051 | 1.028 | 0.7652–1.380 | 0.86 |
Maddrey Df | 1.048 | 1.025–1.073 | >0.0001 | 1.012 | 0.9807–1.044 | 0.46 |
Albumin | 0.2581 | 0.1306–0.51 | 0.0001 | 1.018 | 0.1493–6.934 | 0.99 |
Alk. Phos. | 1.004 | 0.9991–1.008 | 0.12 | |||
ALT | 1.008 | 0.9923–1.024 | 0.32 | |||
AST | 1.009 | 1.004–1.014 | 0.00017 | 1.00 | 0.9935–1.007 | 0.91 |
AST/ALT | 2.594 | 1.518–4.433 | 0.00049 | 5.699 | 1.599–20.310 | 0.0073 |
WBC | 1.011 | 0.8994–1.136 | 0.86 | |||
sCD163 | 14.62 | 1.92–111 | 0.0095 | 1.136 | 0.1069–12.070 | 0.92 |
sCD206 | 17.31 | 2.24–133.8 | 0.0063 | 2.749 | 0.3002–25.180 | 0.37 |
OPN | 14.36 | 2.02–102.1 | 0.0078 | 9.789 | 2.729–35.120 | 0.00047 |
LBP | 2.36 | 0.7833–7.11 | 0.13 |
HR: hazard ratio; CI: Confidence interval; DF: discriminant factor; AST: aspartate aminotransferase; ALT: alanine aminotransferase; AST/ALT: AST-ALT ratio; Alk. Phos.: alkaline phosphatase; WBC: white blood cell; OPN: osteopontin, LBP: lipopolysaccharide binding protein
present/absent